Human Papillomavirus Induced Transformation in Cervical and Head and Neck Cancers

Por Adams, Allie K., Wise-Draper, Trisha M., Wells, Susanne I.
Publicado em 2014

Oncolytic virotherapy for head and neck cancer: current research and future developments

Por Malhotra, Akshiv, Sendilnathan, Arun, Old, Matthew O, Wise-Draper, Trisha M
Publicado no Oncolytic Virother (2015)

Apoptosis Inhibition by the Human DEK Oncoprotein Involves Interference with p53 Functions

Por Wise-Draper, Trisha M., Allen, Hillary V., Jones, Elizabeth E., Habash, Kristen B., Matsuo, Hiroshi, Wells, Susanne I.
Publicado em 2006

Coordinate regulation of Fanconi anemia gene expression occurs through the Rb/E2F pathway

Por Hoskins, Elizabeth E., Gunawardena, Ranjaka W., Habash, Kristen B., Wise-Draper, Trisha M., Jansen, Michael, Knudsen, Erik S., Wells, Susanne I.
Publicado em 2008

Future Directions and Treatment Strategies for Head and Neck Squamous Cell Carcinomas

Por Wise-Draper, Trisha M., Draper, David J., Gutkind, J. Silvio, Molinolo, Alfredo A., Wikenheiser-Brokamp, Kathryn A., Wells, Susanne I.
Publicado em 2012

The Human DEK Proto-Oncogene Is a Senescence Inhibitor and an Upregulated Target of High-Risk Human Papillomavirus E7

Por Wise-Draper, Trisha M., Allen, Hillary V., Thobe, Megan N., Jones, Elizabeth E., Habash, Kristen B., Münger, Karl, Wells, Susanne I.
Publicado em 2005

A patient-derived somatic mutation in the epidermal growth factor receptor ligand-binding domain confers increased sensitivity to cetuximab in head and neck cancer

Por Bahassi, El Mustapha, Li, Ya-Qin, Wise-Draper, Trisha M., Deng, Li, Wang, Jiang, Darnell, Colleen N., Wilson, Keith M., Wells, Susanne I., Stambrook, Peter J., Rixe, Olivier
Publicado no Eur J Cancer (2013)

Overexpression of the cellular DEK protein promotes epithelial transformation in vitro and in vivo

Por Wise-Draper, Trisha M., Mintz-Cole, Rachael A., Morris, Teresa A., Simpson, David S., Wikenheiser-Brokamp, Kathryn A., Currier, Mark A., Cripe, Timothy P., Grosveld, Gerard C., Wells, Susanne I.
Publicado em 2009

DEK Proto-Oncogene Expression Interferes with the Normal Epithelial Differentiation Program

Por Wise-Draper, Trisha M., Morreale, Richard J., Morris, Teresa A., Mintz-Cole, Rachael A., Hoskins, Elizabeth E., Balsitis, Scott J., Husseinzadeh, Nader, Witte, David P., Wikenheiser-Brokamp, Kathryn A., Lambert, Paul F., Wells, Susanne I.
Publicado em 2009

DEK promotes HPV positive and negative head and neck cancer cell proliferation

Por Adams, Allie K., Hallenbeck, Grace E., Casper, Keith A., Patil, Yash J., Wilson, Keith M., Kimple, Randall J., Lambert, Paul F., Witte, David P., Xiao, Weihong, Gillison, Maura L., Wikenheiser-Brokamp, Kathryn A., Wise-Draper, Trisha M., Wells, Susanne I.
Publicado em 2014

A Phase Ib Study of the Dual PI3K/mTOR Inhibitor Dactolisib (BEZ235) Combined with Everolimus in Patients with Advanced Solid Malignancies

Por Wise-Draper, Trisha M., Moorthy, Ganesh, Salkeni, Mohamad A., Karim, Nagla Abdel, Thomas, Hala Elnakat, Mercer, Carol A., Beg, M. Shalaan, O’Gara, Sue, Olowokure, Olugbenga, Fathallah, Hassana, Kozma, Sara C., Thomas, George, Rixe, Olivier, Desai, Pankaj, Morris, John C.
Publicado no Target Oncol (2017)

The human DEK oncogene regulates DNA damage response signaling and repair

Por Kavanaugh, Gina M., Wise-Draper, Trisha M., Morreale, Richard J., Morrison, Monique A., Gole, Boris, Schwemberger, Sandy, Tichy, Elisia D., Lu, Lu, Babcock, George F., Wells, James M., Drissi, Rachid, Bissler, John J., Stambrook, Peter J., Andreassen, Paul R., Wiesmüller, Lisa, Wells, Susanne I.
Publicado em 2011